Shareholder alert: pomerantz law firm investigates claims on behalf of investors of regeneron pharmaceuticals, inc. - regn

New york, ny / accesswire / june 17, 2024 / pomerantz llp is investigating claims on behalf of investors of regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq:regn). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
REGN Ratings Summary
REGN Quant Ranking